Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Zhihuan Luo
Institutions:
Hubei University of Medicine,
Dongfeng General Hospital
Observed institutions:
Hubei University of Medicine,
China National Pharmaceutical Group Corporation (China),
Dongfeng General Hospital
ORCID:
0000-0001-9665-5199
Observed ORCID:
0000-0001-9665-5199
OpenAlex ID:
A5000705671
Red cell distribution width in coronary heart disease: prediction of restenosis and its relationship with inflammatory markers and lipids
2018
·
Hang Qian
, Zhihuan Luo
, et al.
·
Postgraduate Medical Journal
·
31
PHACTR1 gene polymorphism with the risk of coronary artery disease in Chinese Han population
2019
·
Lishan Chen
, Hang Qian
, et al.
·
Postgraduate Medical Journal
·
21
LKB1/AMPK treats myocardial disease by boosting mitochondrial function
2023
·
Zhihuan Luo
, Luyuan Yao
·
International Journal of Cardiology
·
3
The miR-195-3p/BDNF axis is a promising therapeutic for heart failure
2024
·
Luyuan Yao
, Xiaofang Gong
, et al.
·
International Journal of Cardiology
·
1
The miR-137/DEL-1 axis-induced apoptosis as a potential heart failure mechanism
2025
·
Luyuan Yao
, Hao Li
, et al.
·
International Journal of Cardiology
Mendelian randomization and single-cell analysis reveal relationships between sleep disorders and myocardial infarction
2024
·
Zhihuan Luo
, Pan Song
, et al.
·
Research Square
PDF
The miR-26b/CTGF axis: A promising therapeutic mechanism for managing myocardial fibrosis post myocardial infarction
2024
·
Luyuan Yao
, Kun Hao
, et al.
·
International Journal of Cardiology
Mitochondrial dysfunction due to miR-210/Drd5/ROS axis is a potential mechanism of heart failure
2024
·
Zhihuan Luo
, Xiaofang Gong
, et al.
·
International Journal of Cardiology
Show more works
View as search
Works count:
8
Citation count:
56
H-index:
3
I10-index:
2
Year
Topic
Type